Identification of proteins regulated by interferon-alpha in resistant and sensitive malignant melanoma cell lines. 2004

Rachel A Craven, and Anthea J Stanley, and Sarah Hanrahan, and Nick Totty, and David P Jackson, and Razvan Popescu, and Allen Taylor, and Jürgen Frey, and Peter J Selby, and Poulam M Patel, and Rosamonde E Banks
Cancer Research UK Clinical Centre, St. James's University Hospital, Leeds, UK.

Treatment of patients with malignant melanoma with interferon-alpha achieves a response in a small but significant subset of patients. Currently, although much is known about interferon biology, little is known about either the particular mechanisms of interferon-alpha activity that are crucial for response or why only some patients respond to interferon-alpha therapy. Two melanoma cell lines (MeWo and MM418) that are known to differ in their response to the antiproliferative activity of interferon-alpha, have been used as a model system to investigate interferon-alpha action. Using a proteomics approach based on two-dimensional polyacrylamide gel electrophoresis and mass spectrometry, several proteins induced in response to interferon-alpha have been identified. These include a number of gene products previously known to be type I interferon responsive (tryptophanyl tRNA synthetase, leucine aminopeptidase, ubiquitin cross-reactive protein, gelsolin, FUSE binding protein 2 and hPNPase) as well as a number of proteins not previously reported to be induced by type I interferon (cathepsin B, proteasomal activator 28alpha and alpha-SNAP). Although the proteins upregulated by interferon-alpha were common between the cell lines when examined at the level of Western blotting, the disparity in the basal level of cathepsin B was striking, raising the possibility that the higher level in MM418 may contribute to the sensitivity of this cell line to interferon-alpha treatment.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D002401 Cathepsin B A lysosomal cysteine proteinase with a specificity similar to that of PAPAIN. The enzyme is present in a variety of tissues and is important in many physiological and pathological processes. In pathology, cathepsin B has been found to be involved in DEMYELINATION; EMPHYSEMA; RHEUMATOID ARTHRITIS, and NEOPLASM INVASIVENESS. Cathepsin B-Like Proteinase,Cathepsin B1,Cathepsin B Like Proteinase,Proteinase, Cathepsin B-Like
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass

Related Publications

Rachel A Craven, and Anthea J Stanley, and Sarah Hanrahan, and Nick Totty, and David P Jackson, and Razvan Popescu, and Allen Taylor, and Jürgen Frey, and Peter J Selby, and Poulam M Patel, and Rosamonde E Banks
May 1982, Proceedings of the National Academy of Sciences of the United States of America,
Rachel A Craven, and Anthea J Stanley, and Sarah Hanrahan, and Nick Totty, and David P Jackson, and Razvan Popescu, and Allen Taylor, and Jürgen Frey, and Peter J Selby, and Poulam M Patel, and Rosamonde E Banks
February 1981, Journal of interferon research,
Rachel A Craven, and Anthea J Stanley, and Sarah Hanrahan, and Nick Totty, and David P Jackson, and Razvan Popescu, and Allen Taylor, and Jürgen Frey, and Peter J Selby, and Poulam M Patel, and Rosamonde E Banks
September 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
Rachel A Craven, and Anthea J Stanley, and Sarah Hanrahan, and Nick Totty, and David P Jackson, and Razvan Popescu, and Allen Taylor, and Jürgen Frey, and Peter J Selby, and Poulam M Patel, and Rosamonde E Banks
June 1997, International journal of cancer,
Rachel A Craven, and Anthea J Stanley, and Sarah Hanrahan, and Nick Totty, and David P Jackson, and Razvan Popescu, and Allen Taylor, and Jürgen Frey, and Peter J Selby, and Poulam M Patel, and Rosamonde E Banks
January 1976, Biochimie,
Rachel A Craven, and Anthea J Stanley, and Sarah Hanrahan, and Nick Totty, and David P Jackson, and Razvan Popescu, and Allen Taylor, and Jürgen Frey, and Peter J Selby, and Poulam M Patel, and Rosamonde E Banks
April 1978, International journal of cancer,
Rachel A Craven, and Anthea J Stanley, and Sarah Hanrahan, and Nick Totty, and David P Jackson, and Razvan Popescu, and Allen Taylor, and Jürgen Frey, and Peter J Selby, and Poulam M Patel, and Rosamonde E Banks
April 1984, Virology,
Rachel A Craven, and Anthea J Stanley, and Sarah Hanrahan, and Nick Totty, and David P Jackson, and Razvan Popescu, and Allen Taylor, and Jürgen Frey, and Peter J Selby, and Poulam M Patel, and Rosamonde E Banks
October 1998, Lancet (London, England),
Rachel A Craven, and Anthea J Stanley, and Sarah Hanrahan, and Nick Totty, and David P Jackson, and Razvan Popescu, and Allen Taylor, and Jürgen Frey, and Peter J Selby, and Poulam M Patel, and Rosamonde E Banks
October 2003, Gene,
Rachel A Craven, and Anthea J Stanley, and Sarah Hanrahan, and Nick Totty, and David P Jackson, and Razvan Popescu, and Allen Taylor, and Jürgen Frey, and Peter J Selby, and Poulam M Patel, and Rosamonde E Banks
December 1986, Cancer research,
Copied contents to your clipboard!